Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
December 07 2017 - 6:02AM
Edgar (US Regulatory)
Filed pursuant to Rule 424(b)(3)
Registration No. 333-220061
PROSPECTUS SUPPLEMENT
(To prospectus dated August 18, 2017)
CEL-SCI CORPORATION
On July 24, 2017 the Company sold convertible notes in the principal amount
of $1,235,000 to private investors.
On November 2, 2017 the holders of these convertible notes agreed to extend
the maturity date of their notes to September 21, 2018.
In consideration for the extension of the maturity date of the notes, the
Company issued a total of 269,652 Series RR warrants to the note holders that
agreed to the extension. Each Series RR warrant entitles the holder to purchase
one share of the Company's common stock at a price of $1.65 per share at any
time on or before October 30, 2022.
Prospectus Supplement dated December 6, 2017
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Apr 2023 to Apr 2024
